(Q47333592)

English

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes

scientific article published in July 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

type 2 diabetes

0 references

0 references

0 references

circulatory system

1 reference

based on heuristic

inferred from title

author name string

Blonde L

1

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

Klein EJ

2

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

Han J

3

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

Zhang B

4

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

Mac SM

5

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

Poon TH

6

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

Taylor KL

7

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

Trautmann ME

8

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

Kim DD

9

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

Kendall DM

10

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

publication date

1 July 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

8

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

4

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

436-447

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies

1 reference

https://api.crossref.org/works/10.1111/J.1463-1326.2006.00602.X

21 January 2018

Obesity and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111/J.1463-1326.2006.00602.X

21 January 2018

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

1 reference

https://api.crossref.org/works/10.1111/J.1463-1326.2006.00602.X

21 January 2018

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111/J.1463-1326.2006.00602.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111/J.1463-1326.2006.00602.X

21 January 2018

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

1 reference

https://api.crossref.org/works/10.1111/J.1463-1326.2006.00602.X

21 January 2018

Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1111/J.1463-1326.2006.00602.X

21 January 2018

Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111/J.1463-1326.2006.00602.X

21 January 2018

Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111/J.1463-1326.2006.00602.X

21 January 2018

Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats

1 reference

https://api.crossref.org/works/10.1111/J.1463-1326.2006.00602.X

21 January 2018

Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight

1 reference

https://api.crossref.org/works/10.1111/J.1463-1326.2006.00602.X

21 January 2018

Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practice

1 reference

https://api.crossref.org/works/10.1111/J.1463-1326.2006.00602.X

21 January 2018

The Epidemic of Obesity

1 reference

https://api.crossref.org/works/10.1111/J.1463-1326.2006.00602.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2006.00602.X

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/16776751

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47333592&oldid=2152408725"